Knee Injuries

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
MicrofractureN/A1 trial
Active Trials
NCT04537013Terminated82Est. Sep 2025
KARL STORZ Endoscopy
KARL STORZ EndoscopyCA - El Segundo
1 program
Perfusion with Indocyanine greenN/A1 trial
Active Trials
NCT05072717WithdrawnEst. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
KARL STORZ EndoscopyPerfusion with Indocyanine green
Geistlich PharmaMicrofracture

Clinical Trials (2)

Total enrollment: 82 patients across 2 trials

NCT05072717KARL STORZ EndoscopyPerfusion with Indocyanine green

Dynamic Contrast-Enhanced Fluorescence Arthroscopy of Meniscus Pilot

Start: Jan 2022Est. completion: Dec 2023
N/AWithdrawn

Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

Start: Aug 2020Est. completion: Sep 202582 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space